NORTH CHICAGO, Ill. , June 17, 2020 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share.  The cash dividend is payable August 14, 2020 to stockholders of record at the close of business on July 15, 2020 .

NORTH CHICAGO, Ill. , June 3, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the virtual Goldman Sachs 41st Annual Global Healthcare Conference on Wednesday, June 10, 2020 . Richard A. Gonzalez , chairman and chief executive officer,

NORTH CHICAGO, Ill. , May 14, 2020 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the UBS Virtual Healthcare Conference on Wednesday, May 20, 2020 . Michael Severino , M.D., vice chairman and president and Robert A.

- Reports First-Quarter Diluted EPS of $2.02 on a GAAP Basis; Adjusted Diluted EPS of $2.42 - First-Quarter Net Revenues Were $8.619 Billion, an Increase of 10.1 Percent on a GAAP Basis, or 10.7 Percent Operationally - First-Quarter U.S. HUMIRA Net Revenues Were $3.656 Billion, an Increase of 13.7

NORTH CHICAGO, Ill. , April 2, 2020 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its first-quarter 2020 financial results on Friday, May 1, 2020 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8

NORTH CHICAGO, Ill. , Feb. 20, 2020 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share.  The cash dividend is payable May 15, 2020 to stockholders of record at the close of business on April 15, 2020 .

NORTH CHICAGO, Ill. , Feb. 19, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Cowen 40 th Annual Health Care Conference on Wednesday, March 4 , 2020.  Michael Severino , M.D., vice chairman and president and Robert A.

NORTH CHICAGO, Ill. , Feb. 11, 2020 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the SVB Leerink 9 th Annual Global Healthcare Conference on Tuesday, February 25.  Michael Severino , M.D., vice chairman and president and Robert A.

- Reports Full-Year Diluted EPS of $5.28 on a GAAP Basis, an Increase of 44.3 Percent; Adjusted Diluted EPS of $8.94, an Increase of 13.0 Percent - Full-Year Net Revenues Were $33.266 Billion, an Increase of 1.6 Percent on a GAAP Basis; Adjusted Net Revenues Grew 2.7 Percent Operationally;

NORTH CHICAGO, Ill. , Jan. 13, 2020 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its fourth-quarter and full-year 2019 financial results on Friday, February 7, 2020 before the market opens. AbbVie will host a live webcast of the earnings